Phase II evaluation of temozolomide in metastatic choroidal melanoma

Melanoma Research

Volumn 13, Issue 3, 2003, Pages 303-306

  Bedikian, Agop Y ^a   Papadopoulos, Nicholas ^a   Plager, Carl ^a   Eton, Omar ^a   Ring, Sigrid ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Choroidal melanoma; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CHOROID MELANOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFECTION; MALE; METASTASIS; NAUSEA; NEUTROPENIA; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CHOROID NEOPLASMS; DACARBAZINE; FEMALE; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0038177899     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200306000-00013     Document Type: Article

References (15)

1. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, et al. Treatment of uveal melanoma metastatic to the liver. A review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995; 76:1665-1670.
2. Katato K, Liu PY, Sondak V, Flaherty LE. Survival and response to treatment in patients (pts) with metastatic melanoma from intraocular primaries (MMIP) on SWOG studies. Proc Am Soc Clin Oncol 1995; 14:410 (abstract).
3. Nathan FE, Sato T, Hart E, Berd D and Mastrangelo MJ. Response to combination chemotherapy of liver metastases from choroidal melanoma compared with cutaneous melanoma. Proc Am Soc Clin Oncol 1994; 13:394.
4. Bedikian AY, McIntyre S, Hodges C, Mavligit G. Treatment of metastatic uveal and conjunctional melanoma. In: Gershenwald JE (editor): Melanoma. New York: Spring-Verlag; 2003, in press.
5. Atzpodien J, Hanninen E, Kerchner H. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous cisplatin, carmustine and tamoxifen. Eur J Cancer 1995; 31A:876-881.
6. Proebstle TM, Scheibenbogen C, Sterry W, Keilholz U. A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanoma. Eur J Cancer 1996; 32A:1530-1533.
7. Pyrhonen S, Hahka-Kemppinen M, Muhonen T. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. J Clin Oncol 1992; 10:1919-1926.
8. Nathan FE, Berd D, Sato T, Shield JA, Shields CL, De Potter P, Mastrangelo MJ. BOLD+interferon in treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res 1997; 16:201-208.
9. Brock CS, Newlands ES, Wedge SR, Bower M, Evans H, Celquhoun I, et al. Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res 1998; 58 (19):4363-4367.
10. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989; 10:1-10.
11. Middleton MR, Grob JJ, Aaronson N, Fierbeck G, Tilgen W, Seiter S, et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000; 18:158-166.
12. Dorval T, Desjardins L, Tournet I, Levy C, Asselain B, Beuzeboc P, et al. Lack of efficacy of chemotherapy (dacarbazine) in patients with choroidal melanoma: a prospective randomised study. Proc Am Soc Clin Oncol 1997; 16:493a (abstract).
13. Schering Corporation. Temodar® product information, 1999.
14. Myatt N, Cree IA, Kurbacher CM, Foss AJ, Hungerford JL, Plowman PN. The ex vivo chemosensitivity profile of choroidal melanoma. Anticancer Drugs 1997; 8:756-762.
15. Neale MH, Myatt N, Cree IA, Kurbacher CM, Foss AJ, Hungerford JL, Plowman PN. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. Br J Cancer 1999; 79 (9/10):1487-1493.